In2Pharma
  • Home
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Publicity and Compliance
    • Medical writing & training
    • Vigilance
  • About Us
  • News
  • Contact
Select Page
Maximum levels of citrinin in food supplements based on rice fermented with red yeast Monascus purpureus published

Maximum levels of citrinin in food supplements based on rice fermented with red yeast Monascus purpureus published

by In2Pharma | Nov 28, 2019 | News

Europe A new Commission Regulation has been published ((EU) 2019/1901) amending Regulation (EC) No 1881/2006 regarding maximum levels of citrinin in food supplements based on rice fermented with red yeast Monascus Purpureus. The maximum level of citrinin has been set...

EU rules for batch testing of medicinal products after BREXIT

by In2Pharma | Feb 28, 2019 | News

European Union In light of the withdrawal of the United Kingdom from the European Union, the European Commission has published a letter on the rules for batch testing of medicinal products after the Brexit. The competent authorities may allow marketing authorisation...

Updated Annex to the EC guideline on excipients and information in the package leaflet

by In2Pharma | Dec 17, 2018 | News

EMA EMA published an updated Annex to the European Commission guideline on ‘Excipients in the labelling and package leaflet of medicinal products for human use’. The annex contains a list of all excipients known to have a recognised action or effect that need to be...

Recent Posts

  • Update Procedure for MA applications in Luxembourg
  • Labeling Medicinal products
  • New clarification about Day 0 in local literature search published by EMA
  • Revision IML Code of Ethics
  • CBG starts authorizing temporarily different packaging

Follow Us

  • Facebook
  • LinkedIn
Privacy Policy | Cookie Policy | BTW BE 895730662 | +32 16 89 16 00| info@in2pharma.com | Terloonststraat 22, 1910 Kampenhout, België